Cargando…

Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma

Detalles Bibliográficos
Autores principales:	Cho, Ilseung, Utsunomiya, Atae, Tanosaki, Ryuji, Eto, Tetsuya, Fukuda, Takahiro, Suehiro, Youko, Kannagi, Mari, Okamura, Jun, Uike, Naokuni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577795/ http://dx.doi.org/10.1186/1742-4690-12-S1-O16

Ejemplares similares

Augmentation of donor-derived Tax-specific CTL responses by a novel Tax epitope-specific CD4+ helper T-cells in ATL patients after allogeneic hematopoietic stem cell transplantation
por: Hasegawa, Atsuhiko, et al.
Publicado: (2014)

The kinetics of HTLV-1 proviral load after allogeneic hematopoietic cell transplantation with reduced intensity conditioning regimen; a comparison with that from sibling donors and that from unrelated donors
por: Choi, Ilseung, et al.
Publicado: (2014)

The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
por: Suehiro, Youko, et al.
Publicado: (2014)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8(+ )T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers
por: Takamori, Ayako, et al.
Publicado: (2011)

Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers
por: Hasegawa, Atsuhiko, et al.
Publicado: (2011)

Allogeneic BMT in ATL: whom to transplant and which modality to use
por: Kannagi, Mari
Publicado: (2014)

IFN-α suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-α treatment
por: Kinpara, Shuichi, et al.
Publicado: (2014)

Maintenance of long remission in adult T‐cell leukemia by Tax‐targeted vaccine: A hope for disease‐preventive therapy
por: Kannagi, Mari, et al.
Publicado: (2019)

Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
por: Utsunomiya, Atae
Publicado: (2014)

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
por: Utsunomiya, Atae
Publicado: (2019)

The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
por: Kannagi, Mari, et al.
Publicado: (2012)

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
por: Ogura, Michinori, et al.
Publicado: (2020)

Recent advances in the treatment of adult T-cell leukemia-lymphomas
por: Utsunomiya, Atae, et al.
Publicado: (2015)

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL
por: Kannagi, Mari, et al.
Publicado: (2019)

The roles of innate and acquired immune responses on HTLV-I infection
por: Kannagi, Mari, et al.
Publicado: (2011)

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation
por: Fuji, Shigeo, et al.
Publicado: (2017)

Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells
por: Kinpara, Shuichi, et al.
Publicado: (2013)

Short‐term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax‐specific CTL response in adult T‐cell leukemia patients
por: Ishizawa, Miku, et al.
Publicado: (2021)

GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma
por: Muranushi, Hiroyuki, et al.
Publicado: (2020)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study
por: Imaizumi, Yoshitaka, et al.
Publicado: (2020)

Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
por: Tanaka, Norio, et al.
Publicado: (2022)

The Fifth Year of HemaSphere
por: Cools, Jan, et al.
Publicado: (2021)

INFLUENCE OF HEMA CONTENT ON THE MECHANICAL AND BONDING PROPERTIES OF EXPERIMENTAL HEMA-ADDED GLASS IONOMER CEMENTS
por: Lim, Ho-Nam, et al.
Publicado: (2009)

Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP
por: Sato, Tomoo, et al.
Publicado: (2014)

Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey
por: Nosaka, Kisato, et al.
Publicado: (2017)

Early hematopoietic stem cell transplantation improve treatment outcome of aggressive ATL.
por: Uchimaru, Kaoru, et al.
Publicado: (2015)

A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients
por: Miyashita, Kaname, et al.
Publicado: (2016)

Molecular hallmarks of adult T cell leukemia: miRNA, epigenetics, and emerging signaling abnormalities
por: Yamagishi, Makoto, et al.
Publicado: (2014)

Introducing the HemaSphere Controversies Series
por: Eichenauer, Dennis A., et al.
Publicado: (2019)

pHEMA: An Overview for Biomedical Applications
por: Zare, Mina, et al.
Publicado: (2021)

Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP
por: Yamano, Yoshihisa, et al.
Publicado: (2015)

In Vitro and In Vivo Biocompatible and Controlled Resveratrol Release Performances of HEMA/Alginate and HEMA/Gelatin IPN Hydrogel Scaffolds
por: Vuković, Jovana S., et al.
Publicado: (2022)

Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
por: Nosaka, Kisato, et al.
Publicado: (2021)

HEMA Effects on Autophagy Mechanism in Human Dental Pulp Stem Cells
por: Diomede, Francesca, et al.
Publicado: (2019)

Thermoresponsive Smart Copolymer Coatings Based on P(NIPAM-co-HEMA) and P(OEGMA-co-HEMA) Brushes for Regenerative Medicine
por: Tymetska, Svitlana, et al.
Publicado: (2023)

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
por: Ishida, Takashi, et al.
Publicado: (2015)

Etiological factors in primary hepatic B-cell lymphoma
por: Kikuma, Kanta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n74ppgnv4sctaq2g1ergucbgib